Tnc Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TNC encodes an extracellular matrix glycoprotein implicated in neural development, synaptic plasticity, and neuroinflammation. TNC expression increases in AD brain and may contribute to plaque formation and astrocyte reactivity.
The TNC (Tenascin C) gene encodes an extracellular matrix glycoprotein involved in neural development, synaptic plasticity, and tissue repair. Tenascin C is upregulated in response to injury and inflammation and modulates neurite outgrowth, synapse formation, and glial scarring. Elevated TNC is observed in Alzheimer's disease and multiple sclerosis.
This gene is involved in:
| Attribute | Value |
|---|---|
| Gene Symbol | TNC |
| Full Name | Tenascin C |
| Chromosome | 9 |
| Genomic Location | 9q33.1 |
| OMIM | 187380 |
| Ensembl ID | ENSG00000052850 |
| UniProt ID | P24821 |
The TNC gene encodes Tenascin C, a protein expressed in various brain regions including the cerebral cortex, hippocampus, basal ganglia, and cerebellum. The protein is involved in extracellular matrix organization, neural development, and tissue repair.
TNC has been implicated in multiple neurodegenerative diseases:
Tenascin C is an extracellular matrix protein upregulated in AD brain, particularly around amyloid plaques. It may influence Aβ aggregation and astrocyte reactivity. TNC is also involved in synaptic plasticity and is elevated in response to neuronal injury.
Tenascin C is an extracellular matrix protein upregulated in AD brain, particularly around amyloid plaques. It may influence Aβ aggregation and astrocyte reactivity. TNC is also involved in synaptic plasticity and is elevated in response to neuronal injury.
["Alzheimer's Disease", 'Glioblastoma', 'Fibrosis', 'Wound Healing']
TNC is expressed primarily in astrocytes and neurons in the brain. Expression is elevated in AD and PD brain tissue.
| Approach | Status | Description |
|---|---|---|
| Small molecule inhibitors | Preclinical | Various compounds targeting TNC signaling |
| Monoclonal antibodies | Preclinical | Blocking or neutralizing antibodies |
| Gene therapy | Research | Viral vector delivery of TNC-modulating constructs |
The study of Tnc Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Tenascin-C represents a therapeutic target in neurodegeneration:
TNC is used as a biomarker for:
Current research focuses on: